Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 11Lung Neoplasms 10Carcinoma, Non-Small-Cell Lung 7Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Solid Tumor 4Rectal Neoplasms 4Neoplasms 3Lymphoma 3Esophageal Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Tongue Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Thromboembolism 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Teratoma 1Spinal Cord Neoplasms 1Seminoma 1

Interventions

Magnetic Resonance Spectroscopy 17Blood Specimen Collection 8Bevacizumab 8Temozolomide 7Radiotherapy 5Palliative Care 4Surgical Procedures, Operative 3Restraint, Physical 3Radiation 3Biopsy 3Yoga 2Standard of Care 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Psychosocial Intervention 2Perfusion Magnetic Resonance Imaging 2Mind-Body Therapies 2Magnetic Resonance Imaging 2Lomustine 2Gadolinium DTPA 2Elasticity Imaging Techniques 2Early Intervention, Educational 2Drug Therapy 2Diet Therapy 2Dexamethasone 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Glioblastoma × Fluorodeoxyglucose F18 × Clear all
NCT02902757 2025-12-17

FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma

Jonsson Comprehensive Cancer Center

Phase NA Completed
7 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡